Macquarie Group
HSTO

Macquarie Group’s Histogen Inc. Common Stock HSTO Stock Holding History

Macquarie Group’s Portfolio HSTO Stock Details HSTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-39
Closed -$33K – 2325
2018
Q2 		$33K Sell
39
-21
-35% -$17.4K ﹤0.01% 2007
2018
Q1 		$70K Sell
60
-592
-91% -$654K ﹤0.01% 1931
2017
Q4 		$602K Buy
652
+351
+117% +$324K ﹤0.01% 1384
2017
Q3 		$330K Buy
+301
New +$342K ﹤0.01% 1583

Other funds holding HSTO

MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Macquarie Group's HSTO Position: Q3 2018 in Review

Macquarie Group sold out of Histogen Inc. Common Stock (HSTO) in Q3 2018, closing a stake of 39 shares — an estimated $33K sold.

Macquarie Group first reported a position in HSTO in Q3 2017 and held it in 4 quarters. The position peaked at $602K in Q4 2017. 55 funds tracked by Wall St. Rank hold HSTO as of Q3 2018.

  • Macquarie Group reported no remaining Histogen Inc. Common Stock position as of Q3 2018 after selling out during the quarter.
  • Macquarie Group sold 39 Histogen Inc. Common Stock shares in Q3 2018, an estimated $33K.
  • Macquarie Group first reported a position in Histogen Inc. Common Stock in Q3 2017 and held it in 4 quarters.
  • Macquarie Group's Histogen Inc. Common Stock position peaked at $602K in Q4 2017.
  • 55 funds tracked by Wall St. Rank held Histogen Inc. Common Stock as of Q3 2018.

Based on Macquarie Group's 13F filing for Q3 2018, filed 15 Nov 2018.